# Efficacy, Safety and Pharmacokinetics of Different Regimens of Indacaterol

> **NCT01156844** · PHASE2 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 191 (actual)

## Conditions studied

- Persistent Asthma

## Interventions

- **DRUG:** Indacaterol
- **DRUG:** Placebo to Indacaterol

## Key facts

- **NCT ID:** NCT01156844
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2010-07
- **Final completion:** —
- **Target enrollment:** 191 (ACTUAL)
- **Last updated:** 2011-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01156844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01156844, "Efficacy, Safety and Pharmacokinetics of Different Regimens of Indacaterol". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT01156844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*